
ASL pushes for board shakeup at Avadel over handling of sleep drug rollout
(Reuters) -ASL Strategic Value Fund on Monday urged shareholders of Avadel Pharmaceuticals to replace its board, citing mismanagement in the rollout of the drugmaker’s flagship sleep disorder drug Lumryz since its launch two years ago. The hedge fund said …